Literature DB >> 15348351

Binding of vitronectin and clusterin by coagulase-negative staphylococci interfering with complement function.

D Q Li1, F Lundberg, A Ljungh.   

Abstract

Coagulase-negative staphylococci (CoNS) are commonly associated with infections of prosthetic devices mediated by adsorbed host factors on biomaterial surfaces. Complement activation is known to occur and induce unspecific inflammation around the biomaterials. Human vitronectin (Vn) and clusterin (Clu), two potent inhibitors of complement, can be bound by CoNS. With a hypothesis whether binding of Vn or Clu influences complement activation, two measurements were determined. For Vn, complement activation was measured with a mouse anti-activated human C9 antibody. In the presence of Vn-binding strain, Staphylococcus hemolyticus SM13I, complement activation on a surface pre-coated with Vn occurred as it did in the absence of Vn pre-coating. For S. epidermidis 3380, which does not express binding of Vn, complement activation on a Vn-presented surface was significantly decreased. For Clu, erythrocytes lysis was measured to reflect the end product of complement activation (membrane attack complex). The complement-induced hemolysis increased when human serum was pre-incubated with Clu-binding strains, S. epidermidis J9P. The enhancement of hemolysis by J9P decreased when serum was supplemented by exogenous Clu. The data imply that interaction between CoNS and Vn or Clu interferes with one of their physiological functions, complement inhibition. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348351     DOI: 10.1023/a:1012865200458

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  15 in total

1.  Adhesion of staphylococci to chemically modified and native polymers, and the influence of preadsorbed fibronectin, vitronectin and fibrinogen.

Authors:  M Paulsson; M Kober; C Freij-Larsson; M Stollenwerk; B Wesslén; A Ljungh
Journal:  Biomaterials       Date:  1993-09       Impact factor: 12.479

2.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates.

Authors:  S R Partridge; M S Baker; M J Walker; M R Wilson
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 4.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

Authors:  B P Morgan
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

5.  SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.

Authors:  K P Preissner; E R Podack; H J Müller-Eberhard
Journal:  Eur J Immunol       Date:  1989-01       Impact factor: 5.532

6.  Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.

Authors:  E R Podack; K T Preissner; H J Müller-Eberhard
Journal:  Acta Pathol Microbiol Immunol Scand Suppl       Date:  1984

7.  Vitronectin and type-I collagen binding by Staphylococcus aureus and coagulase-negative staphylococci.

Authors:  M Paulsson; T Wadström
Journal:  FEMS Microbiol Immunol       Date:  1990-05

8.  A reexamination of the role of clusterin as a complement regulator.

Authors:  T T Hochgrebe; D Humphreys; M R Wilson; S B Easterbrook-Smith
Journal:  Exp Cell Res       Date:  1999-05-25       Impact factor: 3.905

9.  Activation of the alternative complement pathway by intraocular lenses.

Authors:  B J Mondino; S Nagata; M M Glovsky
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-06       Impact factor: 4.799

10.  Interaction of vitronectin with collagen.

Authors:  C Gebb; E G Hayman; E Engvall; E Ruoslahti
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

View more
  1 in total

1.  Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade.

Authors:  Ahmed S Attia; Sanjay Ram; Peter A Rice; Eric J Hansen
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.